Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
about
Therapies for Prevention and Treatment of Alzheimer's DiseasePotential neuroprotective properties of epigallocatechin-3-gallate (EGCG)Brain "fog," inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolinPolyphenols and the human brain: plant “secondary metabolite” ecologic roles and endogenous signaling functions drive benefitsIn vitro antioxidant and cholinesterase inhibitory activities of methanolic fruit extract of Phyllanthus acidus.Inhibitory effects of magnolol and honokiol on human calcitonin aggregation.Effects and possible mechanisms of action of acacetin on the behavior and eye morphology of Drosophila models of Alzheimer's disease.3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signalingAre Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?Multiple mechanisms of iron-induced amyloid beta-peptide accumulation in SHSY5Y cells: protective action of negletein.Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.Flavonoids and Their Glycosides as Anti-amyloidogenic Compounds: Aβ1-42 Interaction Studies to Gain New Insights into Their Potential for Alzheimer's Disease Prevention and Therapy.Acute effects of a wild green-oat (Avena sativa) extract on cognitive function in middle-aged adults: A double-blind, placebo-controlled, within-subjects trial.Flavonoid glucosylation by non-Leloir glycosyltransferases: formation of multiple derivatives of 3,5,7,3',4'-pentahydroxyflavane stereoisomers.In Vitro Screening of Three Indian Medicinal Plants for Their Phytochemicals, Anticholinesterase, Antiglucosidase, Antioxidant, and Neuroprotective Effects.Attenuation of neurobehavioral and neurochemical abnormalities in animal model of cognitive deficits of Alzheimer's disease by fermented soybean nanonutraceutical.In Vitro Modulation of TrkB Receptor Signaling upon Sequential Delivery of Curcumin-DHA Loaded Carriers Towards Promoting Neuronal Survival.Involvement of PKCα and ERK1/2 signaling pathways in EGCG's protection against stress-induced neural injuries in Wistar rats.Nutrition: Review on the Possible Treatment for Alzheimer's Disease.β-amyloid cytotoxicity is prevented by natural achillolide A.Computational insights into the inhibition and destabilization of morin on the oligomer of full-length human islet amyloid polypeptide.Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.Controlled fluorescence quenching by antibody-conjugated graphene oxide to measure tau protein.Quercetin enrich diet during the early-middle not middle-late stage of alzheimer's disease ameliorates cognitive dysfunction.Molecular insight into amyloid oligomer destabilizing mechanism of flavonoid derivative 2-(4′ benzyloxyphenyl)-3-hydroxy-chromen-4-one through docking and molecular dynamics simulationsEffects of hydroxyl group variations on a flavonoid backbone toward modulation of metal-free and metal-induced amyloid-β aggregation
P2860
Q26740007-BCBA5643-24D6-491B-B567-02D954F851F4Q26748605-E84513B7-1AB2-464E-B6C6-7CB7E664C73DQ26802187-E27D4CE7-3D51-4564-9C8D-3CA78CB06017Q26992098-2B21DA63-E099-4A84-A4FF-BCC21F91BF6EQ35836683-21B0A302-9488-4A58-8CB1-888649805179Q36012254-4B862D67-D0CF-411D-9151-707A10EC1A7FQ36245937-DF33A25E-DEDE-46E3-A066-7F55E60896D8Q36413548-B61A321B-0EED-41F6-89D9-2B8163E5004DQ38690585-9BC41BC0-6586-4198-B335-560F86400EF4Q38953899-161B0F5F-D30B-48C9-929C-E8BC4EC37142Q39186980-6852F5F3-5BB0-491A-BEBF-38B0810578CBQ39263678-D9467010-B3AE-4C70-A697-9A375C79F942Q40262160-43D1F19D-4DE3-4443-8501-7B5D0F6B895AQ41131961-9555B6C3-84C1-454E-A21E-DB19DB0B6160Q46248223-1A6A4523-22BC-40EF-83A1-7F3268E12257Q47936218-1ECE385B-C3CD-4E0B-9C48-37F83CBD6238Q48136178-07785819-2CAC-44D1-9E21-3CB20B73BF2FQ48335155-95928F31-216C-4FAA-BE92-3AEE5E6836CAQ49652662-0E6E67BC-7482-4342-B7FA-8A404DA20F3DQ52652781-A47D0786-291F-4BD3-8E81-794D6142DD26Q53313558-FEC0AF58-45D9-4CB1-BF32-341C97C5AFC0Q53396112-B7D70C71-D160-47B9-90FC-2324E880854FQ55155704-1E2251CF-5861-4F0A-9E9A-7C209CC86A99Q55334689-39E8F54C-B9D8-40E5-9E56-6008FFAEB7E0Q57781259-4E10C2E8-15DD-4582-A2E1-A7080EC03DE1Q57975781-BA8C88EA-B077-4E15-AF16-3DDDB4436D0E
P2860
Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Flavonoids as therapeutic comp ...... volved in Alzheimer's disease.
@en
type
label
Flavonoids as therapeutic comp ...... volved in Alzheimer's disease.
@en
prefLabel
Flavonoids as therapeutic comp ...... volved in Alzheimer's disease.
@en
P2860
P50
P356
P1476
Flavonoids as therapeutic comp ...... nvolved in Alzheimer's disease
@en
P2093
Jens Wiltfang
P2860
P356
10.1021/CN400213R
P577
2014-01-03T00:00:00Z